Literature DB >> 16246517

Prediction of the risk of hepatic failure in patients with portal vein invasion hepatoma after hepatic resection.

C B Hsieh1, C Y Yu, C Tzao, H C Chu, T W Chen, H F Hsieh, Y C Liu, J C Yu.   

Abstract

AIM: Hepatic failure can develop after curative hepatectomy in patients with a hepatocellular carcinoma (HCC) invading the portal vein, because of cirrhosis and excessive tissue loss. This study aimed to identify the risk factors for hepatic failure in such patients.
METHOD: Forty patients with an HCC invading the portal vein underwent curative hepatectomy from January 1995 to June 2003. Eight patients developed hepatic failure and died within 3 months. Possible risk factors for this were analysed using univariate and multivariate regression. These included the liver function index, surgical blood loss, tumour pattern, portal hypertension, estimated residual liver volume measured by computed tomography (ERLV(CT)) and estimated residual liver volume using the indocyanine green (ICG) retention rate at 15 min (ERLV(ICG15)).
RESULTS: The ERLV(CT) smaller than the ERLV(ICG15) and presence of portal hypertension were independent risk factors for post-hepatectomy hepatic failure.
CONCLUSION: Having portal vein invasion HCC with portal hypertension or an ERLV(CT) less than an ERLV(ICG15) are significant predictors of post-hepatectomy hepatic failure. These factors are important considerations for patients with portal vein invasion HCC who could undergo curative hepatic resection.

Entities:  

Mesh:

Year:  2005        PMID: 16246517     DOI: 10.1016/j.ejso.2005.09.003

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  12 in total

1.  Efficacy of hepatic resection vs transarterial chemoembolization for solitary huge hepatocellular carcinoma.

Authors:  Shao-Liang Zhu; Jian-Hong Zhong; Yang Ke; Liang Ma; Xue-Mei You; Le-Qun Li
Journal:  World J Gastroenterol       Date:  2015-08-28       Impact factor: 5.742

2.  Hepatic resection versus transarterial chemoembolization for patients with Barcelona Clinic Liver Cancer intermediate stage Child-Pugh A hepatocellular carcinoma.

Authors:  Yin-Nong Zhao; Yong-Quan Zhang; Jia-Zhou Ye; Xing Liu; Hong-Zhi Yang; Feng-Yun Cong; Bang-De Xiang; Fei-Xiang Wu; Liang Ma; Le-Qun Li; Hai-Hong Ye
Journal:  Exp Ther Med       Date:  2016-10-17       Impact factor: 2.447

3.  Comparing hepatic resection and transarterial chemoembolization for Barcelona Clinic Liver Cancer (BCLC) stage B hepatocellular carcinoma: change for treatment of choice?

Authors:  Chin-Ta Lin; Kuo-Feng Hsu; Teng-Wei Chen; Jyh-Cherng Yu; De-Chuan Chan; Chih-Yung Yu; Tsai-Yuan Hsieh; Hsiu-Lung Fan; Shih-Ming Kuo; Kuo-Piao Chung; Chung-Bao Hsieh
Journal:  World J Surg       Date:  2010-09       Impact factor: 3.352

Review 4.  A review of factors predicting perioperative death and early outcome in hepatopancreaticobiliary cancer surgery.

Authors:  Chris D Mann; Tom Palser; Chris D Briggs; Iain Cameron; Myrrdin Rees; John Buckles; David P Berry
Journal:  HPB (Oxford)       Date:  2010-08       Impact factor: 3.647

Review 5.  Quantitative assessment of hepatic function and its relevance to the liver surgeon.

Authors:  G Morris-Stiff; D Gomez; R Prasad
Journal:  J Gastrointest Surg       Date:  2008-07-12       Impact factor: 3.452

6.  Efficacy of hepatic resection for huge (≥ 10 cm) hepatocellular carcinoma: good prognosis associated with the uninodular subtype.

Authors:  Shao-Liang Zhu; Jie Chen; Hang Li; Le-Qun Li; Jian-Hong Zhong
Journal:  Int J Clin Exp Med       Date:  2015-11-15

7.  Point-of-care continuous (13)C-methacetin breath test improves decision making in acute liver disease: results of a pilot clinical trial.

Authors:  Gadi Lalazar; Tomer Adar; Yaron Ilan
Journal:  World J Gastroenterol       Date:  2009-02-28       Impact factor: 5.742

8.  Obesity Does Not Influence Outcomes in Hepatocellular Carcinoma Patients following Curative Hepatectomy.

Authors:  Zhe Guo; Jun Zhang; Jing-Hang Jiang; Le-Qun Li; Bang-De Xiang
Journal:  PLoS One       Date:  2015-05-12       Impact factor: 3.240

9.  Comparison of long-term survival of patients with solitary large hepatocellular carcinoma of BCLC stage A after liver resection or transarterial chemoembolization: a propensity score analysis.

Authors:  Shao-Liang Zhu; Yang Ke; Yu-Chong Peng; Liang Ma; Hang Li; Le-Qun Li; Jian-Hong Zhong
Journal:  PLoS One       Date:  2014-12-26       Impact factor: 3.240

10.  Comparison of long-term survival of patients with BCLC stage B hepatocellular carcinoma after liver resection or transarterial chemoembolization.

Authors:  Jian-Hong Zhong; Bang-De Xiang; Wen-Feng Gong; Yang Ke; Qin-Guo Mo; Liang Ma; Xing Liu; Le-Qun Li
Journal:  PLoS One       Date:  2013-07-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.